Cargando…
Nivolumab-induced synovitis is characterized by florid T cell infiltration and rapid resolution with synovial biopsy-guided therapy
BACKGROUND: Immune checkpoint inhibitors (ICIs) are associated with rheumatic and musculoskeletal immune-related adverse events (irAEs) in 5%–20% of patients. Currently, patients refractory to corticosteroids and conventional disease-modifying antirheumatic drugs (cDMARD) are treated with biological...
Autores principales: | Murray-Brown, William, Wilsdon, Tom D, Weedon, Helen, Proudman, Susanna, Sukumaran, Shawgi, Klebe, Sonja, Walker, Jennifer G, Smith, Malcolm D, Wechalekar, Mihir D |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7311067/ https://www.ncbi.nlm.nih.gov/pubmed/32571993 http://dx.doi.org/10.1136/jitc-2019-000281 |
Ejemplares similares
-
Triple DMARD treatment in early rheumatoid arthritis modulates synovial T cell activation and plasmablast/plasma cell differentiation pathways
por: Walsh, Alice M., et al.
Publicado: (2017) -
Standardisation of synovial biopsy analyses in rheumatic diseases: a consensus of the EULAR Synovitis and OMERACT Synovial Tissue Biopsy Groups
por: Najm, Aurélie, et al.
Publicado: (2018) -
Correction to: Standardisation of synovial biopsy analyses in rheumatic diseases: a consensus of the EULAR Synovitis and OMERACT Synovial Tissue Biopsy Groups
por: Najm, Aurélie, et al.
Publicado: (2018) -
Editorial: Synovial tissue biopsy research
por: Veale, Douglas J., et al.
Publicado: (2022) -
Eosinophilic Vasculitis and Arteritic Anterior Ischemic Optic Neuropathy Associated With Anti-PD-L1 Therapy
por: Berry, Ella C., et al.
Publicado: (2022)